Home › Diffuse Large B-Cell Lymphoma › North Carolina › Durham

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Durham, NC

14 pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Durham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Nagre-recruitPhase 2

Duke Blood Cancer Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06500273

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Nagre-recruitPhase 3

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06091865

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Nagre-recruitPhase 2

University of North Carolina Medical Center ( Site 0136), Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06890884

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi ang layo

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Nagre-recruitObservasyonal na pag-aaral

Duke University Medical Center - Division of Hematologic Malignancies, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06116110

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

Duke Cancer Institute, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

Duke University Medical Center - Division of Hematologic Malignancies, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

Registry of Older Patients With Cancer

Nagre-recruitObservasyonal na pag-aaral

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo

Edad 65 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT01137825

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

Nagre-recruitPhase 1

Duke Univerisity, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT04775745

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Nagre-recruitObservasyonal na pag-aaral

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo

Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 27, 2025 · NCT01137643

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Nagre-recruitPhase 1

University of North Carolina, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05780034

A Study of NX-1607 in Adults With Advanced Malignancies

Nagre-recruitPhase 1

University of North Carolina, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT05107674

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Nagre-recruitPhase 2

UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 26, 2024 · NCT06238648

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Durham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.